(AOF) – Smaio announces a turnover up 120% in 2023, to 5.4 million euros. This specialist in complex spinal surgery with an offering made up of software, implantable devices and associated services, specifies that this increase is driven by the milestone payment of $3 million from NuVasive during the first half of 2023 and the acceleration of sales of the Kheiron system in the fourth quarter of 2023 (+40% year-on-year).
“Obtaining 510(k) certification by the FDA on the personalized version of our surgical planning software was an important first milestone, allowing us to receive the payment of 3 million dollars from our American partner , NuVasive”, specifies boss Philippe Roussouly.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
